Find Clinical Trial

Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes

← Back
Study Phase

Phase 4

Therapeutic Area


IndicationDiabetes - Type II
SponsorServier (Tianjin) Pharmaceutical Co. LTD.
Active substance/
Medical device


Active Substance CodeS005702
Protocol CodeIC4-5702-205-CHN
NCT CodeNCT00736515

Documents and links

Scientific publication READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.